Electrical Fault Risk Leads HeartWare to Recall Some HVAD Implantable Heart Pumps
HeartWare International (NSDQ:HTWR)HeartWare this week recalled some of its HVAD implantable heart pumps on the risk of electrical faults from driveline contamination.
The recall affects an unspecified number of the left ventricular assist devices, according to an August 15 letter the Framingham, Mass.-based company sent to physicians who implant the pump. Connector contamination of the driveline most often occurred in the 1st 30 days, according to HeartWare, which agreed in June to a $1.1 billion acquisition by Medtronic (NYSE:MDT).
The recall affects an unspecified number of the left ventricular assist devices, according to an August 15 letter the Framingham, Mass.-based company sent to physicians who implant the pump. Connector contamination of the driveline most often occurred in the 1st 30 days, according to HeartWare, which agreed in June to a $1.1 billion acquisition by Medtronic (NYSE:MDT).